CLINICAL_TRIALS
trial_result
· 2021-04-29
Clinical Trial Update: A Bioequivalence Study of Testosterone Cypionate in Hypogonadal Males [Phase 1]
Summary
Phase 1 bioequivalence study of testosterone cypionate in hypogonadal males has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hypogonadism | Phase 1 | Status: COMPLETED | Results posted: 2021-04-29